How the mcl deal works, page-22

Very true, I have noticed that you usually mention the good points as well.
MLC has a lot to offer a stagnant bauxite company, the directors have offered a premium to keep the company viable IMO.

The big question is why the extension to Medcan acquisition? You think Medcan may want more now that they have a new license? Or Medcan want more shares as the sp has dropped? I can't see QBL reneging from the deal.
All IMO.
Shareholders come first!